CUSIP 92765F108COMRYIQ4 2025
18 filings · latest Feb 14, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Motiv8 Investments LLC | 14 | $0 |
| 4 | Feb 14, 2023 | Biotechnology Value Fund L P | 13G/A | 5.2% | 1.99M | SEC |
| 5 | Jan 10, 2023 | Schindel Yair Chaim | 13D/A | 14.0% | 5.36M | SEC |
| 6 | Jan 10, 2023 | Schindel Yair Chaim | 13D/A | 14.0% | 5.36M | SEC |
| 7 | Jul 8, 2022 | Blackrock Inc. | 13G | 1.4% | 542.4K | SEC |
| 8 | Feb 15, 2022 | Lytton Laurence W | 13G/A | 0.7% | 255.9K | SEC |
| 9 | Feb 14, 2022 | Aisling Capital IV, LP | 13G | 0.8% | 288.6K | SEC |
| 10 | Feb 14, 2022 | Biotechnology Value Fund L P | 13G/A | 4.9% | 1.83M | SEC |
See the full Schedule 13D/13G history for Viracta Therapeutics Inc.
Unlock full history